Skip to main content

Day: June 16, 2020

Tiger Merger Sub Co. Extends Expiration Date to June 26, 2020 for Tender Offers and Consent Solicitations Relating to Tech Data Corporation’s 3.700% Senior Notes due 2022 and 4.950% Senior Notes due 2027

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) — Tiger Merger Sub Co. (the “Offeror”), an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo”), announced today that it has further extended the Expiration Date (as defined in the Offer to Purchase (as defined below)) for the previously announced Tender Offers and Consent Solicitations (each as defined below) relating to Tech Data Corporation’s (i) 3.700% Senior Notes due 2022 (the “2022 Notes”) and (ii) 4.950% Senior Notes due 2027 (the “2027 Notes” and, together with the 2022 Notes, the “Notes”). The Expiration Date was previously extended to June 16, 2020. As a result of this further extension, the Expiration Date will now be 5:00 p.m., New York City time, on June 26, 2020 (unless further...

Continue reading

Novartis Cosentyx® receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis

FDA approval for Cosentyx® is based on the Phase III PREVENT trial,  demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis (axSpA) disease spectrum There are an estimated 2.7M people living with axial spondyloarthritis (axSpA) in the US; however, it remains significantly underdiagnosed1,2 nr-axSpA approval is the fourth indication for Cosentyx, which is backed by five years of clinical data supporting long-term safety and efficacy across moderate to severe plaque psoriasis (PsO), psoriatic arthritis (PsA) and ankylosing spondylitis (AS)3-8Basel, June 17, 2020 — Novartis, a leader in rheumatology and immuno-dermatology, today announced that the US Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) for the treatment of active non-radiographic...

Continue reading

LGI Homes Expands Denver Footprint With the Opening of Two New Communities

DENVER, June 16, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) today announced the opening of two new communities, both north of downtown Denver. LGI Homes brings two unique product line offerings to the Denver area with community openings in Keenesburg and Mead. Both new construction neighborhoods showcase a lineup of affordable, quality-built homes that will attract Denver home shoppers at a time when interest rates are low and the demand for homeownership is high.Evans Place, located in the town of Keenesburg, offers three- and four-bedroom homes ranging in size from 1,293 to 2,363 square feet with prices starting in the low-$300s. These new homes include an incredible array of stylish features and energy-efficient upgrades found in LGI Homes’ CompleteHome™ package. From Wi-Fi-enabled garage door openers and programmable...

Continue reading

Eastern Zinc Announces Intention to Change Name and Stock Ticker Symbol

VANCOUVER, British Columbia, June 16, 2020 (GLOBE NEWSWIRE) — Eastern Zinc Corp. (“Eastern Zinc” or the “Company”) (CSE:EZNC | OTC:ETZCF) is pleased to announce that its board of directors has approved a corporate name change to “Major Precious Metals Corp.” and has reserved the new ticker symbol “SIZE”.The proposed Company name and stock trading symbol changes are subject to approval from the Canadian Securities Exchange (CSE) and receipt of new CUSIP and ISIN numbers. The Company will update the market of the effective date of the name and ticker symbol change once available.The Company believes that the name and ticker symbol change better reflects the Company’s diversified portfolio of exploration properties. The Company’s objectives continue to be the acquisition, exploration and development of natural resource...

Continue reading

Zomedica Appoints New Interim CEO to Lead Organization Through Inaugural Product Launch

ANN ARBOR, Mich., June 16, 2020 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (“Zomedica” or the “Company”) (NYSE American: ZOM), a veterinary diagnostic company, announced that it has appointed Robert Cohen, formerly of EmboMedics, Inc., as its Interim Chief Executive Officer, effective immediately.Mr. Cohen brings to Zomedica more than 15 years executive leadership and operations experience from the medical device market, and biotechnology and pharmaceutical industries. Mr. Cohen graduated from Bates College, received an M.B.A. Pfizer/Columbia University Graduate School of Business and has a J.D. from the University of Maine School of Law. The Board of Directors hired Mr. Cohen in part because of his successful track record in launching medical devices in the biotech space.  Mr. Cohen will be responsible for driving the completion...

Continue reading

NBT Bancorp Inc. Announces Pricing of Subordinated Notes Offering

NORWICH, N.Y., June 16, 2020 (GLOBE NEWSWIRE) — NBT Bancorp Inc. (“NBT” or the “Company”) (NASDAQ: NBTB), the holding company for NBT Bank, N.A. (the “Bank”), today announced the pricing of its public offering of $100 million aggregate principal amount of 5.000% Fixed-to-Floating Rate Subordinated Notes due 2030 (the “Notes”). The price to the public for the Notes was 100% of the principal amount of the Notes. Interest on the Notes will accrue at a rate equal to (i) 5.000% per annum from the original issue date to, but excluding, July 1, 2025, payable semiannually in arrears, and (ii) a floating rate per annum equal to a benchmark rate, which is expected to be Three-Month Term SOFR (as defined in the Notes), plus a spread of 485 basis points from, and including, July 1, 2025, payable quarterly in arrears. The Notes are intended to...

Continue reading

Delta 9 Enters Partnership Agreement with Manitoba Hotel Association

WINNIPEG, Manitoba, June 16, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has entered into a partnership agreement with the Manitoba Hotel Association (“MHA”) to be their exclusive cannabis partner.  “As one of Canada’s few vertically integrated cannabis producers, Delta 9 is proud to be partnering with the MHA. The MHA membership includes the majority of hotels in Manitoba and has one of the highest membership rates among hotel associations in North America,” said John Arbuthnot, CEO of Delta 9. “We look forward to the opportunity to work with MHA members in helping them become established cannabis retailers and to distribute locally produced Delta 9 branded cannabis products throughout Manitoba hotels.”This opportunity provides Delta 9 access...

Continue reading

WMG Acquisition Corp. Announces Pricing of $535 Million Offering of Senior Secured Notes

NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that its wholly-owned subsidiary, WMG Acquisition Corp. (the “Company”), has priced $535,000,000 aggregate principal amount of 3.875% senior secured notes due 2030 (the “Notes”). The offering is expected to close on June 29, 2020, subject to customary closing conditions.The Company intends to use the net proceeds of the offering, together with the net proceeds from the potential offering of euro-denominated notes and cash on hand, to fund (i) the purchase price of any and all of the Company’s outstanding 5.000% senior secured notes due 2023 tendered and accepted by the Company in its previously announced tender offer and consent solicitation that commenced on June 16, 2020, (ii) the conditional redemption of any remaining...

Continue reading

Pretivm Files Final Base Shelf Prospectus

VANCOUVER, British Columbia, June 16, 2020 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) announces that it has filed a final short form base shelf prospectus with the securities commissions in each of the provinces and territories of Canada, and a corresponding shelf registration statement on Form F-10 with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended.The base shelf prospectus, together with the corresponding shelf registration statement on Form F-10, will allow Pretivm to offer up to US$600,000,000 of common shares, debt securities, warrants, units, subscription receipts and share purchase contracts from time to time over the 25-month period after Canadian securities regulatory authorities have issued a receipt for the final short form base...

Continue reading

Middlesex Water CEO to Participate in Baird Virtual Food, Fuel and Water Symposium on June 17

ISELIN, N.J., June 16, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX), has announced that its Chairman, President and CEO Dennis Doll will be participating in the Baird Food, Fuel and Water Symposium on June 17 at 8 a.m. EDT.  Mr. Doll will provide a company overview and participate in a fireside chat with Baird Sr. Research Analyst, Ben Kallo, CFA and Baird Research Associate David Katter discussing the company and the water industry. A replay of the webcast will be available following the symposium on Middlesex Water’s website www.middlesexwater.com under Investors at the News & Events/Presentations Tab.About Middlesex Water CompanyOrganized in 1897, Middlesex Water provides regulated and unregulated water and wastewater utility services primarily in New Jersey and Delaware through various subsidiary companies. Media...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.